Intrexon Corporation (Public - NYSE: XON) forms collaborations to create biologically based products and processes using synthetic biology. The Company designs, builds and regulates gene programs, which are deoxyribonucleic acid (DNA) sequences that consist of genetic components. The Company's synthetic biology capabilities include the ability to control the amount, location and modification of biological molecules to control the function and output of living cells and optimize for desired results at an industrial scale. Its technologies combine the principles of precision engineering, statistical modeling, automation and production at an industrial scale. The Company's technologies include UltraVector gene design and fabrication platform, and its associated library of modular DNA components; Cell Systems Informatics; RheoSwitch inducible gene switch; AttSite Recombinases; Protein Engineering; Laser-Enabled Analysis and Processing, or LEAP, and ActoBiotics platform.
Spanish Fishing Consortia Impact Artisanal Fishing in Central America Nicaragua
The following is an excerpt from an article published by IPS-Inter Press Service:
Spanish transnational fishing companies, especially in Nicaragua, El Salvador and Guatemala, have aimed to exploit ec...
Vietnam's shrimp exports reached over 686 million USD in Q1/2024 Viet Nam
In March 2024, shrimp exports reached nearly 272 million USD, up 3% over the same period last year. Although the growth rate is still modest, this shows that purchasing power from the markets is recov...
The Norwegian Pelagic Fishing Course in Week 17 Norway
Good week for blue whiting in the Faroese zone, but still poor for the sandeel
Blue whiting:
Last week, 19,499 tonnes of coal mullet were registered from 19 different boats. The fishing has ...
Copyright 1995 - 2024 Seafood Media Group Ltd.| All Rights Reserved. DISCLAIMER